PTLF (Petlife Pharmaceuticals) Other Current Liabilities: $0.59 Mil (As of Feb. 2018)


What is Petlife Pharmaceuticals Other Current Liabilities?

Petlife Pharmaceuticals PTLF Other Current Liabilities is $0.59 Mil as of Feb. 2018.

Petlife Pharmaceuticals's other current liabilities for the quarter that ended in Feb. 2018 was $0.59 Mil.

Petlife Pharmaceuticals's quarterly other current liabilities increased from Aug. 2017 ($0.10 Mil) to Nov. 2017 ($0.45 Mil) and increased from Nov. 2017 ($0.45 Mil) to Feb. 2018 ($0.59 Mil).

Petlife Pharmaceuticals's annual other current liabilities stayed the same from Aug. 2015 ($0.00 Mil) to Aug. 2016 ($0.00 Mil) but then increased from Aug. 2016 ($0.00 Mil) to Aug. 2017 ($0.10 Mil).

Petlife Pharmaceuticals Other Current Liabilities Related Terms

Petlife Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Other Current Liabilities Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.10

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.10 0.45 0.59

Petlife Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.59 Mil mean?
Petlife Pharmaceuticals (PTLF) has a Other Current Liabilities of $0.59 Mil as of Feb. 2018. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Petlife Pharmaceuticals.
Is Petlife Pharmaceuticals' Other Current Liabilities too high?
Petlife Pharmaceuticals' current Other Current Liabilities is $0.59 Mil.
How does Petlife Pharmaceuticals' Other Current Liabilities compare to PCYN and YBAO?
Petlife Pharmaceuticals' Other Current Liabilities of $0.59 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Petlife Pharmaceuticals. Petlife Pharmaceuticals's current Other Current Liabilities is $0.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Other Current Liabilities of $0.59 Mil. The current Other Current Liabilities is $0.59 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Other Current Liabilities is $0.59 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.